2 results
Approved WMOCompleted
Primary objective: Determine whether treatment with a PI3K inhibitor (BYL719 or buparlisib) plus letrozole leads to an increase in pathologic response compared to treatment with placebo plus letrozole in patients with hormone receptor-positive HER2-…
Approved WMOCompleted
The aim of the study is to determine the mechanical effect of EXO-L on the range of motion of the talocrural and subtalar joint in individuals with chronic ankle instability.